Metabolic Endocrinology Hypogonadism

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Hypogonadism Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Hypogonadism Projects
--Acrux Limited
--Ardana plc
--Ascend Therapeutics, Inc.
--Bayer Schering Pharma AG
--Clarus Therapeutics Inc.
--Ferring Pharmaceuticals A/S
--GlaxoSmithKline plc
--Indevus Pharmaceuticals Inc
--ProStrakan Group plc
--Repros Therapeutics Inc
--Urigen Pharmaceuticals, Inc.

--Top Companies in early stage Hypogonadism Projects
--Antares Pharma Inc
--Bayer Schering Pharma AG
--Crimson Pharma
--Ligand Pharmaceuticals Inc
--MacroChem Corporation
--ProStrakan Group plc
--Takeda Pharmaceutical Company Limited
--TAP Pharmaceutical Products Inc.
--TransPharma Medical Ltd.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View